Shiloh
Editor, Senior Moderator
Source: https://www.nature.com/articles/d41586-022-01209-w
Risky ‘gain-of-function’ studies need stricter guidance, say US researchers
After a delay caused by the COVID-19 pandemic, US biosecurity board revisits policies governing risky pathogen experiments.
Max Kozlov
03 May 2022
Researchers and biosecurity specialists are calling on the US government to issue clearer guidance about experiments it might fund that would make pathogens more transmissible or deadly. They made these pleas on 27 April, during the first of a series of public listening sessions organized by the US National Science Advisory Board for Biosecurity (NSABB). The sessions are part of a months-long review, conducted by the NSABB, of US policies governing risky pathogen research.
The shifting sands of ‘gain-of-function’ research
The board, which advises the US Department of Health and Human Services (HHS), was supposed to begin this review in 2020, but the COVID-19 pandemic delayed it. Given that enhanced pathogens could accidentally cause disease outbreaks, the need for the review is now greater than ever, some researchers say...
Risky ‘gain-of-function’ studies need stricter guidance, say US researchers
After a delay caused by the COVID-19 pandemic, US biosecurity board revisits policies governing risky pathogen experiments.
Max Kozlov
03 May 2022
Researchers and biosecurity specialists are calling on the US government to issue clearer guidance about experiments it might fund that would make pathogens more transmissible or deadly. They made these pleas on 27 April, during the first of a series of public listening sessions organized by the US National Science Advisory Board for Biosecurity (NSABB). The sessions are part of a months-long review, conducted by the NSABB, of US policies governing risky pathogen research.
The shifting sands of ‘gain-of-function’ research
The board, which advises the US Department of Health and Human Services (HHS), was supposed to begin this review in 2020, but the COVID-19 pandemic delayed it. Given that enhanced pathogens could accidentally cause disease outbreaks, the need for the review is now greater than ever, some researchers say...
